share_log

Assure | 10-Q: Q1 2024 Earnings Report

Assure | 10-Q: Q1 2024 Earnings Report

Assure | 10-Q：2024財年一季報
美股SEC公告 ·  2024/06/07 15:37

Moomoo AI 已提取核心訊息

Assure Holdings reported Q1 2024 revenue of $9,000, down 92% from $115,000 in Q1 2023, with a net loss of $3.76 million compared to $3.14 million loss year-over-year. The decline reflects the company's strategic exit from managed service agreements. Operating expenses increased 16% to $3.73 million, primarily due to higher legal fees related to asset sales and merger activities.The company completed the sale of most clinical operations to MPOWER Health on March 26, 2024 for up to $4.5 million, including $2.3 million in cash and potential earnout payments of $2.2 million. Additionally, Assure entered into a merger agreement with Danam Health in February 2024, where former Assure shareholders will own approximately 10% of the combined company post-merger.The company faces continued Nasdaq listing compliance challenges, though received an extension until July 22, 2024 to meet requirements through the Danam merger. Working capital was negative $19 million as of March 31, 2024, with management noting substantial doubt about continuing as a going concern. The company settled a DOJ investigation for $1 million payable over 12 months.
Assure Holdings reported Q1 2024 revenue of $9,000, down 92% from $115,000 in Q1 2023, with a net loss of $3.76 million compared to $3.14 million loss year-over-year. The decline reflects the company's strategic exit from managed service agreements. Operating expenses increased 16% to $3.73 million, primarily due to higher legal fees related to asset sales and merger activities.The company completed the sale of most clinical operations to MPOWER Health on March 26, 2024 for up to $4.5 million, including $2.3 million in cash and potential earnout payments of $2.2 million. Additionally, Assure entered into a merger agreement with Danam Health in February 2024, where former Assure shareholders will own approximately 10% of the combined company post-merger.The company faces continued Nasdaq listing compliance challenges, though received an extension until July 22, 2024 to meet requirements through the Danam merger. Working capital was negative $19 million as of March 31, 2024, with management noting substantial doubt about continuing as a going concern. The company settled a DOJ investigation for $1 million payable over 12 months.
提供術中神經監測（IONM）服務的Assure Holdings Corp.報告稱，2024年第一季度的營業收入同比2023年同期出現了顯着下降。營業收入從115,000美元下降到9,000美元，下降了92％，而收入成本從679,000美元降至475,000美元，下降了30％。公司的毛利率提高了17％，總營業費用增加了16％。Assure的經營虧損達4196,000美元，比上一年的3777,000美元增加了11％。淨虧損擴大了20％至3761,000美元。儘管面臨這些挑戰，終止營運收入增長114％至908,000美元。Assure已與DOJ達成和解協議，同意支付100萬美元來免除其民事或行政貨...展開全部
提供術中神經監測（IONM）服務的Assure Holdings Corp.報告稱，2024年第一季度的營業收入同比2023年同期出現了顯着下降。營業收入從115,000美元下降到9,000美元，下降了92％，而收入成本從679,000美元降至475,000美元，下降了30％。公司的毛利率提高了17％，總營業費用增加了16％。Assure的經營虧損達4196,000美元，比上一年的3777,000美元增加了11％。淨虧損擴大了20％至3761,000美元。儘管面臨這些挑戰，終止營運收入增長114％至908,000美元。Assure已與DOJ達成和解協議，同意支付100萬美元來免除其民事或行政貨幣性索賠。該公司還獲得了納斯達克的延期，以在2024年7月22日之前恢復遵守上市要求。Assure的未來計劃包括在2024年終止剩餘的管理服務協議（MSA）關係，並與Danam Health，Inc.合併，預計合併後，Assure的前股權持有人將擁有合併公司的約10％股權。合併後，Assure將更名爲Danam Health Holdings Corp.，並由Danam的新領導層和董事會成員管理。

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

獨立文件6  查看翻譯

獨立文件7  查看翻譯

獨立文件8  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    英偉達
    NVDA
    -- 109.670
    特斯拉
    TSLA
    -- 263.550
    CoreWeave
    CRWV
    -- 40.000
    Palantir
    PLTR
    -- 85.850
    谷歌-C
    GOOG
    -- 156.060
    解鎖完整榜單
    重估中國資產
    繼中國開創性的DeepSeek技術推出之後，華爾街大行重估對中國市場的投資前景。
    熱門討論
    FOMC維持利率但不確定性高企：美股後市走向如何？
    🎙️討論 1. 美聯儲強調政策路徑存在「高度不確定性」，你更關注利率預期變化還是經濟數據對市場的短期影響？ 2. 若核心通脹維持高位，哪類板塊更具交易機會——防禦型股票還是科技成長股？ 展开
    聯邦公開市場委員會新聞發佈會，2025年3月19日